Zacks Analyst Blog Highlights: Cleveland BioLabs, First Advantage Corporation, Nabors Industries Ltd., Johnson & Johnson and Shutterfly, Inc.

CHICAGO--(BUSINESS WIRE)--Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Cleveland BioLabs (NASDAQ: CBLI), First Advantage Corporation (NASDAQ: FADV), Nabors Industries Ltd. (NYSE: NBR), Johnson & Johnson (NYSE: JNJ) and Shutterfly, Inc. (NASDAQ: SFLY).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579

Here are highlights from Thursday’s Analyst Blog:

CBLI a Bio-Defense Play

Cleveland BioLabs (NASDAQ: CBLI) is a drug discovery and development company, utilizing its discoveries regarding apoptosis to treat cancer and protect normal tissues from exposure to radiation and other stresses. The company is developing its compounds for Biodefense, treatment of cancer and tissue protection due to external stress.

We are excited about the company's robust pipeline of clinical candidates, its unique positioning, and the immense market potential if the company can successfully develop and commercialize the compounds. We maintain our Buy rating on the stock with a revised target price of $3.00.

First Advantage Downgraded

First Advantage Corporation (NASDAQ: FADV) is a provider of risk mitigation solutions. The current business segments are as follows: lender services, data services, dealer services, employer services, multifamily services, and investigative and litigation support services.

We are downgrading our rating on shares of First Advantage Corporation from Hold to Sell. We believe the shares of FADV are overvalued near current levels. The shares of FADV are currently trading at a P/E multiple of 16x estimated 2009 EPS. We believe that, given the present earnings growth outlook and the current level of economic uncertainty, the current valuation is unwarranted.

Nabors Industries Now a Sell

Barbados-based Nabors Industries Ltd. (NYSE: NBR) conducts oil, gas and geothermal land drilling operations, and is the largest land-drilling contractor in the world. It is also one of the largest land well servicing companies and workover contractors in the U.S.

We are downgrading Nabors Industries shares to Sell from Hold to reflect the weak outlook for the North American onshore drilling market. The expected drop off in drilling activities, in response to a combination of commodity-price weakness and credit market tightness, will weigh on the fortunes of all oilfield service players.

J&J Strong on Fundamentals

Johnson & Johnson (NYSE: JNJ) has an enormously diverse revenue stream consisting of market leading products in all three of its business segments. However, due to a number of products expected to experience declining sales, revenue growth will likely slow in 2009. Incremental earnings growth will come in the form of improving margins and share buybacks.

J&J's consistency, product diversity, financial stability and long-term growth potential make it a very attractive holding in this turbulent market. We rate the stock a Buy based on the stock's attractive valuation and strong company fundamentals. Our price target is $70.

Shutterfly Views Challenges Ahead

Headquartered in Redwood City, California, Shutterfly, Inc. (NASDAQ: SFLY) is a leading provider of Internet-based social expression and personal publishing service. With its broad range of leveraged technology, manufacturing, web-design and merchandising capabilities, Shutterfly enables its customers to share, print and preserve their digital photographs.

We currently rate the shares of SFLY a Hold. Challenges remain to the company's outlook, including those related to consumer spending in the slowing economy and potential pressures stemming from price discounting by competitors. However, the company remains in very strong financial position, with zero debt and approximately $3.25 in cash and securities on the balance sheet.

Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: http://at.zacks.com/?id=2649.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: http://at.zacks.com/?id=2677

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4580.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.